The investigators aim to examine whether amantadine can help patients recover from stroke.
This will be a blinded randomized clinical trial (RCT). Patients will be randomized
post-ischemic or hemorrhagic stroke either to the placebo arm or amantadine arm. Patients
will be on study drug or placebo for 1 month but will be enrolled for 3 months total. At
various time points they will be examined and fill out questionnaires to determine their
level of stroke recovery.